betmiga50mg30tab old

Betmiga 50mg tablets contain mirabegron, a selective beta-3 adrenergic receptor agonist. It works by relaxing the detrusor muscle of the bladder, which increases bladder capacity and delays the initial urge to urinate. This medication is specifically prescribed for the symptomatic treatment of overactive bladder (OAB) syndrome, helping to manage symptoms such as urinary urgency, increased micturition frequency, and urgency incontinence. The prolonged-release formulation ensures a steady release of the active ingredient throughout the day for continuous symptom control.